Acceleron Pharma (XLRN) Misses Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. VZ
9. LMT
10. SPY

Go back to Acceleron Pharma (XLRN) Misses Q3 EPS by 1c

Acceleron Pharma (XLRN) PT Raised to $62 at H.C. Wainwright

November 7, 2017 2:02 PM EST

H.C. Wainwright analyst Edward White raised his price target on Acceleron Pharma (NASDAQ: XLRN) to $62.00 (from $57.00) while maintaining a Buy rating.

White notes Luspatercept and Sotatercept updates expected at ASH.

... More